Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol Maleate Gel for Proliferating Superficial Infantile Hemangioma
NCT06677853Phase 3Completed
- Sponsor
- Auson Pharmaceuticals
- Start
- Oct 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of timolol maleate gel + placebo in infantile hemangioma (IH), sponsored by Auson Pharmaceuticals. Started Oct 2020; status: completed.
02
Drugs
timolol maleate gel + placebo
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT06677853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06677853.